Abstract Library

#3932 Artisan: Prospective phase II trial of TheraSphere Selective Internal Radiation Therapy (SIRT) for liver metastases in neuroendocrine tumors (NETs)

Introduction: The liver is the commonest site of metastases and is an independent predictor of poor outcome. SIRT allows delivery of high dose radiation to liver metastases and has shown promise in the management of NETs. We determined the safety and efficacy of SIRT in those with inoperable liver metastases in a prospective study.

Conference:

Presenting Author: Ahmed Q

Authors: Ahmed Q, Doumanoglou N, Evans J, Martinez M, Ward C,

Keywords: radioembolization, carcinoid, neuroendocrine, metastases,

#3169 Transarterial chemoembolization for neuroendocrine tumor liver metastases: A 15-years monocentric experience

Introduction: Sequential Transarterial Chemoembolization (TACE) may be considered repetitively during the course of the disease. However, evaluation methods remain controversial.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Touloupas C, Faron M, Deschamps F, Hadoux J, Roux C,

Keywords: neuroendocrine, liver metastases, chemoembolization, intra-arterial therapies, mRECIST,

#2786 Outcome of NET Liver Metastases Treated by TAE Using Microspheres

Introduction: Liver metastases are common in patients with neuroendocrine tumors (NETs), which are associated with the prognosis. Transarterial embolization (TAE) is one of the options for selective therapy in patients with multiple unresectable progressive liver metastases after chemotherapy.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Chen X

Authors: Chen X, Hu L,

Keywords: transarterial embolization, neuroendocrine tumors, NETs, microspheres,

#2041 Hepatic Tumor Burden Can be Reduced Rapidly and Effectively by Trans-Arterial Embolization Combined with Systemic Therapy in Patients with Neuroendocrine Tumor Liver Metastasis (NETLM)

Introduction: The main tumor burden of patients with neuroendocrine tumor liver metastasis is comprised by hepatic lesions.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Liu Y

Authors: Liu Y, Wang Y, Lian F, Shen L, Chen L,

Keywords: intervention, TAE, liver metastasis,

#2040 Hepatic Tumor Burden Can Be Reduced Rapidly and Effectively by Trans-Arterial Embolization Combined with Systemic Therapy in Patients with Neuroendocrine Tumor Liver Metastasis (NETLM)

Introduction: The main tumor burden of patients with neuroendocrine tumor liver metastasis is comprised by hepatic lesions.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: Liu Y

Authors: Liu Y, Wang Y, Lian F, Shen L, Chen L,

Keywords: intervention, TAE, liver metastasis,